Ginkgo Bioworks

Ginkgo Bioworks, founded in 2008, has raised $796M to date from investors including Illumina, Viking Global, Felicis Ventures, Gates Foundation, and NSF grants. The Boston-based synthetic-biology company programs microbes for flavors, fragrances, sweeteners, agricultural inputs, and biopharma partnerships. Its platform combines high-throughput biology, automation, and software to accelerate R&D and commercialize bio-manufactured products. Funding and grants have supported platform scaling, foundry automation, and product commercialization. Ginkgo is positioned to expand industrial and consumer synthetic biology solutions globally while optimizing large-scale bio-manufacturing efficiency.